209 related articles for article (PubMed ID: 17521712)
1. Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
Thromb Res; 2007; 121(3):293-9. PubMed ID: 17521712
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.
Chalikias GK; Tziakas DN; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
Int J Cardiol; 2007 May; 117(3):333-9. PubMed ID: 16859776
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
[TBL] [Abstract][Full Text] [Related]
5. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD40L: risk prediction after acute coronary syndromes.
Varo N; de Lemos JA; Libby P; Morrow DA; Murphy SA; Nuzzo R; Gibson CM; Cannon CP; Braunwald E; Schönbeck U
Circulation; 2003 Sep; 108(9):1049-52. PubMed ID: 12912804
[TBL] [Abstract][Full Text] [Related]
9. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE
Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173
[TBL] [Abstract][Full Text] [Related]
10. Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes.
Tousoulis D; Antoniades C; Nikolopoulou A; Koniari K; Vasiliadou C; Marinou K; Koumallos N; Papageorgiou N; Stefanadi E; Siasos G; Stefanadis C
Eur J Clin Invest; 2007 Aug; 37(8):623-8. PubMed ID: 17635572
[TBL] [Abstract][Full Text] [Related]
11. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome.
Kilic T; Ural D; Ural E; Yumuk Z; Agacdiken A; Sahin T; Kahraman G; Kozdag G; Vural A; Komsuoglu B
Heart; 2006 Aug; 92(8):1041-6. PubMed ID: 16547209
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
13. Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker?
Jessani S; Lip GY
Thromb Res; 2007; 121(3):289-91. PubMed ID: 17610938
[No Abstract] [Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
Desideri G; Panichi V; Paoletti S; Grassi D; Bigazzi R; Beati S; Bernabini G; Rosati A; Ferri C; Taddei S; Ghiadoni L;
Nephrol Dial Transplant; 2011 Sep; 26(9):2983-8. PubMed ID: 21303961
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
Duygu H; Barisik V; Kurt H; Turk U; Ercan E; Kose S
Europace; 2008 Feb; 10(2):210-4. PubMed ID: 18184662
[TBL] [Abstract][Full Text] [Related]
17. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
[TBL] [Abstract][Full Text] [Related]
18. [Serum sCD40L detection for risk evaluation of acute coronary syndromes].
Xu BL; Bei CH; Wang R; Lei XX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1656-7. PubMed ID: 17121725
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
